The aim of this study was to assess VEGF level profile in the early UA patient cohort during first visit to a rheumatologist office, assess the association with sociodemographic, clinical, laboratory and ultrasound findings, and evaluate VEGF potential as a prognostic marker for arthritis outcome. The gene discussed is VEGFA; the disease is arthritic joint disease.